Log in to save to my catalogue

A selective antagonist of prostaglandin E receptor subtype 4 attenuates abdominal aortic aneurysm

A selective antagonist of prostaglandin E receptor subtype 4 attenuates abdominal aortic aneurysm

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6144453

A selective antagonist of prostaglandin E receptor subtype 4 attenuates abdominal aortic aneurysm

About this item

Full title

A selective antagonist of prostaglandin E receptor subtype 4 attenuates abdominal aortic aneurysm

Publisher

United States: John Wiley & Sons, Inc

Journal title

Physiological reports, 2018-09, Vol.6 (18), p.e13878-n/a

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Abdominal aortic aneurysm (AAA) is a progressive disease that has an increasing prevalence with aging, but no effective pharmacological therapy to attenuate AAA progression is currently available. We reported that the prostaglandin E receptor EP4 plays roles in AAA progression. Here, we show the effect of CJ‐42794, a selective EP4 antagonist, on AA...

Alternative Titles

Full title

A selective antagonist of prostaglandin E receptor subtype 4 attenuates abdominal aortic aneurysm

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6144453

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6144453

Other Identifiers

E-ISSN

2051-817X

DOI

10.14814/phy2.13878

How to access this item